Canadian approval for ZymeTx' point-of-care flu test:
This article was originally published in Clinica
Executive Summary
ZymeTx has received the go-ahead to market its ZstatFlu test in Canada. The product allows doctors to diagnose influenza A and B in under 60 minutes. It was the first point-of-care test for influenza to receive US clearance in September 1997 (see Clinica 775, p 17).